Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1445-73-4 Chemical Structure| 1445-73-4

Structure of 1-Methyl-4-piperidone
CAS No.: 1445-73-4

Chemical Structure| 1445-73-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1445-73-4 ]

CAS No. :1445-73-4
Formula : C6H11NO
M.W : 113.16
SMILES Code : CN1CCC(=O)CC1
MDL No. :MFCD00006191
InChI Key :HUUPVABNAQUEJW-UHFFFAOYSA-N
Pubchem ID :74049

Safety of [ 1445-73-4 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H225
Precautionary Statements:P210-P233-P240-P241-P242-P243-P280-P303+P361+P353-P370+P378-P403+P235-P501
Class:3
UN#:1224
Packing Group:

Computational Chemistry of [ 1445-73-4 ] Show Less

Physicochemical Properties

Num. heavy atoms 8
Num. arom. heavy atoms 0
Fraction Csp3 0.83
Num. rotatable bonds 0
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 35.85
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

20.31 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.54
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.28
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.1
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.07
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.1
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.47

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.37
Solubility 48.8 mg/ml ; 0.431 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

0.31
Solubility 233.0 mg/ml ; 2.06 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.82
Solubility 17.0 mg/ml ; 0.151 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.19 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.0

Application In Synthesis of [ 1445-73-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1445-73-4 ]

[ 1445-73-4 ] Synthesis Path-Downstream   1~16

  • 1
  • [ 2346-00-1 ]
  • [ 1445-73-4 ]
  • [ 55090-01-2 ]
  • 2
  • [ 1445-73-4 ]
  • [ 80-11-5 ]
  • [ 1859-33-2 ]
  • [ 599-66-6 ]
  • 3
  • [ 1445-73-4 ]
  • [ 65854-91-3 ]
  • [ 85732-71-4 ]
  • 4
  • [ 1445-73-4 ]
  • [ 1004-38-2 ]
  • 5-(1-Methyl-1,2,3,6-tetrahydro-pyridin-4-yl)-pyrimidine-2,4,6-triamine [ No CAS ]
  • 5
  • [ 1445-73-4 ]
  • [ 14150-94-8 ]
  • [ 123792-64-3 ]
YieldReaction ConditionsOperation in experiment
48% With ammonia; In methanol; at 50℃;Schlenk technique; In a schlenk reactor, a solution of <strong>[14150-94-8]1-methyl-3,5-dinitro-1H-pyridin-2-one</strong> (5.00 g, 25.11mmol) and 1-methyl-4-piperidone (3.13 g, 27.62 mmol) in ammonia (7N in MeOH) (43mL) was stirred overnight at 50 C. After cooling down to rt, the mixture was evaporatedin vacuo, taken-up in DCM and a saturated aqueous solution of NaHCO3 was added. Thelayers were separated and the aqueous layer was extracted with DCM (three times). The combined organic layers were dried over MgSO4, filtered off and evaporated in vacuo togive 2.32 g of intermediate 128 (48% yield, reddish solid) which was used in the next step without further purification.
  • 6
  • [ 1445-73-4 ]
  • [ 16732-66-4 ]
  • 6-bromo-2,3,4,5-tetrahydro-2-methyl-1H-pyrido[4,3-b]indole [ No CAS ]
  • 7
  • [ 1445-73-4 ]
  • [ 98276-57-4 ]
  • [ 521074-54-4 ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide; In ethanol; water; at 60℃; for 16.0h; Reference Example 65 2-methyl-1,2,3,4-tetrahydrobenzo[b][1,6] naphthyridin-7-amine A solution of <strong>[98276-57-4]2,4-diaminobenzaldehyde</strong> (1.00 g, 7.34 mmol), 1-methyl-4-piperidinone (1.08 ml, 8.81 mmol) and 4N aqueous sodium hydroxide solution (11 ml) in ethanol (70 ml) was stirred at 60C for 16 hrs, and the solvent was evaporated under reduced pressure.. The residue was dissolved in ethyl acetate, washed with aqueous potassium carbonate solution and saturated brine, and dried over anhydrous sodium sulfate.. The obtained crude product was purified by NH-silica gel chromatography (elute solvent; ethyl acetate) and treated with ethyl acetate - isopropyl ether (1:5) to give the title compound (666 mg) as a powder.1H-NMR (DMSO-d6) delta: 2.37 (3H, s), 2.71 (2H, t, J = 6.0 Hz), 2.96 (2H, t, J = 6.0 Hz), 3.56 (2H, s), 5.58 (2H, br), 6.80 (1H, d, J = 2.1 Hz), 6.87 (1H, dd, J = 2.1, 8.4 Hz), 7.48 (1H, d, J = 8.4 Hz), 7.64 (1H, s).
  • 8
  • [ 1445-73-4 ]
  • CH3 [ No CAS ]
  • [ 32566-01-1 ]
  • 1'-methyl-5,6-dihydrospiro[1H-indolo[3,2-c]quinoline-6,4'-piperidine] [ No CAS ]
YieldReaction ConditionsOperation in experiment
With acetic acid; In ethanol; EXAMPLE 4 1'-Methyl-5,6-dihydrospiro[1H-indolo[3,2-c]quinoline-6,4'-piperdine] To a solution prepared from 8 g of <strong>[32566-01-1]2-(2-aminophenyl)indole</strong>, 2.5 ml of acetic acid and 100 ml of ethanol was added 5.15 g of 1-methyl-4-piperidone. The mixture was refluxed for 6 hours. Concentration gave a gum which was triturated with dilute NH4 OH and the resultant solid was collected. Flash chromatography using 10% CH3 OH/CH2 Cl2 as an eluent gave 4.15 g of yellow solid, m.p. 228-230 dec. Analysis. Calculated for C20 H21 N3: 79.17% C, 6.98% H, 13.85% N. Found: 78.85% C, 7.09% H, 13.68% N.
  • 9
  • [ 1445-73-4 ]
  • [ 1532-71-4 ]
  • isoquinolyl-1-lithium [ No CAS ]
  • lithium 1-methyl-4-(1-isoquinolyl)-piperidin-4-olate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride; In water; EXAMPLE 12 A solution of 11.3 g. of 1-methylpiperidin-4-one in 120 ml. of ether is added dropwise to a stirred isoquinolyl-1-lithium solution, freshly prepared from 20.8 g. of <strong>[1532-71-4]1-<strong>[1532-71-4]bromoisoquinoline</strong></strong> and n-butyllithium in 400 ml. of ether, at 0°, under dry nitrogen. The mixture is stirred for 2 hours more at 0°. Water (50 ml.) and then 100 ml. of 5percent hydrochloric acid are added dropwise to decompose the lithium 1-methyl-4-(1-isoquinolyl)-piperidin-4-olate formed.
  • 10
  • [ 1445-73-4 ]
  • [ 62830-55-1 ]
  • [ 1147939-50-1 ]
YieldReaction ConditionsOperation in experiment
To a suspension of <strong>[62830-55-1]4-iodophenylhydrazine hydrochloride</strong> (2.0 g, 0.0074 mol) in dioxane (30 mL) at RT was added cone. H2SO4 (0.7 mL, 0.0171 mol) dropwise and the reaction mixture was stirred for 5 min. To this was added N-methyl-4-piperidone (0.838 g, 0.0074 mol) and the reaction mixture was stirred at RT for 10 min and heated at 70 0C for 90 min. Reaction monitored by TLC. The solvent was evaporated and pH adjusted to 9-10 by 10percent KOH Solution. The product was extracted with (3x50 rnL) EtOAc. Combined organic layer washed with water and brine and dried over sodium sulfate, concentrated under vacuum and product purified by column chromatography (100-200 mesh silica) in solvent system (0-10percent, DCM/MeOH). Obtained 1.8g of brown solid. 1U NMR (CDCl3, free base) d (ppm) 7.70 (s, IH), 7.38 (d, IH), 7.05 (d, IH), 3.60 (s, 2H), 2.90 (m, 4H), 2.58 (s, 3H).
  • 11
  • [ 1445-73-4 ]
  • [ 62254-74-4 ]
  • [ 1578301-12-8 ]
YieldReaction ConditionsOperation in experiment
49% With sodium methylate; In methanol; at 20℃; for 4h; General procedure: Method A [31]: To a solution of the starting aldehyde (1.5 mmol) and ketone (0.75 mmol) in methanol (10 mL) was added the solution of sodium methoxide in methanol (5.4 M, 0.14 mL,0.75 mmol), and the mixture was stirred for 4-18 h and monitored with TLC. When the reaction was completed, the following two work-up procedures were applied. Procedure 1: if precipitate was observed, the precipitate was filtered and rinsed with cold methanol. Procedure 2: if no precipitate was observed, then saturated solution of ammonium chloride was added, and the subsequent mixture was extracted with dichloromethane. The organic layer was dried over anhydrous MgSO4. The solvent was evaporated under vacuum to give a crude product, which was purified by preparative TLC (3e5% methanol in dichloromethane) or column chromatography (2% methanol in dichloromethane).
49% With sodium methylate; In methanol; [0067] The solution of sodium methoxide in methanol (5.4M, 0.14 mL, 0.75 mmol) was added to a solution of 5-methylisoxazole-3-carbaldehyde (166.5 mg, 1.5 mmol) andN-methylpiperidone (85 mg, 0.75 mmol) in methanol (10mL). The mixture was stirred for 4 h -18 h and monitored withThin Layer Chromatography (TLC). When the reaction wascompleted, saturated solution of ammonium chloride wasadded, and the subsequent mixture was extracted with dichloromethane.The organic layer was dried over anhydrousMgS04 . The solvent was evaporated under vacuum to give acrude product, which was purified by preparative TLC (5%methanol in dichloromethane ).[0068] NMR spectra were obtained on a Bruker Fourier300spectrometer in CDC3, CD30D, or DMSO-d6. The chemicalshifts are given in d (ppm) referenced to the respective solventpeak, and coupling constants are reported in Hz. All reagentsand solvents were purchased from commercial sources andwere used without further purification. Silica gel columnchromatography was performed using silica gel (32-63 pt).Preparative thin-layer chromatography (PTLC) separationswere carried out on 1000f1AnaTech thin layer chromatographyplates (Lot No. 13401).[0069] (2E,6E)-2,6-Bis((5-methylisoxazol-3-yl)methylene)cyclohexanone (general formula (I), 5BHR-124 sidegroup, shown as Compound 8 in Table 4) was prepared in49% yield as a yellow crystal: mp. 155-156 C. IR (neat) v max:3129, 2943, 1685, 1636, 1598, 1426, 1267, 1181, 910, 783cm-1.1H NMR (300 MHz, CD3Cl) o. 2.47 (s, 6H), 2.52 (s,3H), 3.90 (s, 4H), 6.11 (s, 2H), 7.42 (s, 2H). 13C NMR (75MHz, CD3Cl) o. 12.2, 45.7, 57.5, 103.6, 121.9, 138.1, 158.8,169.9, 186.5. HR-MS (ESI) m/z: calcd for C16H18N30 3[M+H]: 300.1348. found 300.1345.
  • 12
  • [ 1445-73-4 ]
  • [ 5417-17-4 ]
  • 3,5-bis(2-chloro-3,4-dimethoxybenzylidene)-1-methylpiperidin-4-one [ No CAS ]
YieldReaction ConditionsOperation in experiment
61% With sodium hydroxide; In ethanol; at 5 - 27℃; General procedure: The a,b-unsaturated carbonyl-based cyclohexanone compoundswere synthesized using direct coupling method as reportedpreviously28,37 (Table 2). The ketones were reacted with suitablearomatic aldehyde at molar ratio 1:2 using base-catalyzed claisen-schmidt condensation to synthesize 21 new compounds (3a?3u). Characterization data of only three compounds (3c, 3f, 3o)was reported previously.37 The flow diagram for the synthesis ofa,b-unsaturated carbonyl-based compounds is shown in Scheme 1.The ketone (10 mmol, 1 equiv) and aromatic aldehyde (20 mmol,2 equiv) were mixed in round bottom flask using 25 mL ethanolat 5 C. 40percent sodium hydroxide solution (in ethanol) was added tothis solution. The mixture was stirred for 1?24 h at 27 C. The precipitateappearance and color variation indicated product formation.The reaction was monitored using TLC while acidified icewas added to stop it when completed. Recrystallization and/or columnchromatography were used to isolate the compounds. 4.3.14 3,5-Bis-(2-chloro-3,4-dimethoxy-benzylidene)-1-methyl-piperidin-4-one (3n) Yield: 61percent; Mp: 144-145 °C; 1H NMR (500 MHz, CDCl3) delta: 7.87 (s, 2H), 6.92 (d, J = 8.5 Hz, 2H), 6.55 (d, J = 8.5 Hz, 2H), 3.82 (s, 12H), 2.78 (s, 4H), 2.14 (s, 3H); 13C NMR (500 MHz, CDCl3) delta: 185.5, 149.7, 147.4, 145.1, 142.2, 135.8, 132.1, 105.7, 98.7, 56.8, 56.5, 41.5, 17.1; HRMS (ESI) m/z: 479.55 [M+H]+, Microanalysis calculated for C24H25Cl2NO5 (478.37): C, 60.26; H, 5.27; N, 2.93. Found: C, 60.52; H, 5.45; N, 2.72.
  • 13
  • [ 1445-73-4 ]
  • [ 454482-11-2 ]
  • 14
  • [ 1445-73-4 ]
  • [ 186534-02-1 ]
  • 3,5-bis(3,5,6-trimethylpyrazin-2-ylmethylene)-1-methylpiperidin-4-one oxime [ No CAS ]
  • 15
  • [ 1445-73-4 ]
  • [ 186534-02-1 ]
  • 3,5-bis-(3,5,6-trimethylpyrazin-2-ylmethylene)-1-methylpiperidin-4-one [ No CAS ]
YieldReaction ConditionsOperation in experiment
55% With sodium hydroxide; In ethanol; at 5 - 27℃; General procedure: New a, b-unsaturated carbonyl-based compounds (5a-g and 6au)were synthesized using direct coupling technique [40] (Scheme 1). The reaction was carried out using base-catalyzed Claisen-Schmidt condensation reaction, by reacting different types of ketoneswith appropriate aromatic aldehyde at molar ratio 2:1 tosynthesize new compounds (5a-g) and at molar ratio 1:1 for (6a-u).For synthesis of 6a-u first 5a-g intermediates were synthesized andin second step appropriate aldehydes were reacted with intermediates.The detailed method of synthesis has already beenreported by us previously [38,40]. Scheme 1 shows the highlights ofsynthesis of compound 3, 4 and a, b-unsaturated carbonyl-basedcompounds along with oxime derivatives. 15 mL ethanol wastaken in a round bottom flask and aromatic aldehyde (20 mmol, 2equivalent) and specific ketone (10 mmol,1 equivalent) were addedand dissolved using a stirrer for 2-3 min at 5 C. Into the abovesolution, 40% NaOH solution in ethanol was added drop wise andthe mixture was stirred for 1-24 h at 27 C. The color change andprecipitate formation in the reaction mixture showed productformation. TLC was used to monitor the reaction and acidified icewas added to quench the reaction once completed. The isolation ofcompounds was done by recrystallization and/or by using columnchromatography.
  • 16
  • [ 1445-73-4 ]
  • [ 26830-29-5 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1445-73-4 ]

Ketones

Chemical Structure| 77542-18-8

A171540 [77542-18-8]

1-Ethyl-1-methyl-4-oxopiperidin-1-ium iodide

Similarity: 0.96

Chemical Structure| 5355-68-0

A147972 [5355-68-0]

1-Isopropyl-4-piperidone

Similarity: 0.92

Chemical Structure| 72544-16-2

A179080 [72544-16-2]

1-Isobutylpiperidin-4-one

Similarity: 0.92

Chemical Structure| 19869-42-2

A268552 [19869-42-2]

1-Methylazepan-4-one hydrochloride

Similarity: 0.88

Chemical Structure| 41979-39-9

A160445 [41979-39-9]

Piperidin-4-one hydrochloride

Similarity: 0.88

Related Parent Nucleus of
[ 1445-73-4 ]

Piperidines

Chemical Structure| 77542-18-8

A171540 [77542-18-8]

1-Ethyl-1-methyl-4-oxopiperidin-1-ium iodide

Similarity: 0.96

Chemical Structure| 5355-68-0

A147972 [5355-68-0]

1-Isopropyl-4-piperidone

Similarity: 0.92

Chemical Structure| 72544-16-2

A179080 [72544-16-2]

1-Isobutylpiperidin-4-one

Similarity: 0.92

Chemical Structure| 320589-77-3

A514065 [320589-77-3]

Piperidin-4-one hydrochloride hydrate

Similarity: 0.88

Chemical Structure| 41979-39-9

A160445 [41979-39-9]

Piperidin-4-one hydrochloride

Similarity: 0.88